According to Recent Study, the global radiation dermatitis market reached value at US$ 405 Mn in 2020 and predicted to hit US$ 700 million by 2030, expanding at a CAGR of 5.1% from 2021 to 2030.
According to Recent Study, the global radiation dermatitis market reached value at US$ 405 Mn in 2020 and predicted to hit US$ 700 million by 2030, expanding at a CAGR of 5.1% from 2021 to 2030.
Rise in prevalence of cancer and increase in adoption of radiation therapy for cancer treatment are projected to drive the global radiation dermatitis market during the forecast period.
Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/38181
New Biocompatible, Biodegradable Nanomaterials Pave Way for Innovations in Dressings
The radiation dermatitis market is expected to reach a valuation of ~US$ 700 Mn by the end of 2030. Manufacturers are boosting their output capacities in wound dressings that are highly elastic and flexible in nature. However, it has been found that these dressings in some cases may damage fragile skin and may not prevent maceration. This has created a need for new biocompatible and biodegradable nanomaterials that help in regulating all phases of wound healing.
Companies in the radiation dermatitis market are increasing their R&D capabilities to develop dressings that incorporate antibacterial and self-healing properties.
Non-steroidal Ingredients in Creams Ameliorate Radiation Dermatitis Symptoms
Adverse effects of any radiation therapy, such as in the case of breast cancer, may lead to issues such as skin irritation, tenderness in treated area, and changes in skin color. In order to minimize these adverse effects, manufacturers in the radiation dermatitis market are innovating in corticosteroid creams and ointments. Topical sucralfate or hyaluronic acid hold promising potentials in ameliorating the symptoms of patients suffering from radiation dermatitis.
Herbal ingredients such as extracts from the calendula plant are gaining prominence in corticosteroid creams and ointments for topical applications. Patients are preferring non-steroidal ingredients in creams. This explains why the radiation dermatitis market is projected to expand at a modest CAGR of ~5% during the assessment period.
Film-forming Gel a Breakthrough Innovation for Enabling Faster Wound Healing
Innovations in wound dressings are creating value grab opportunities for companies in the radiation dermatitis market. Stratpharma - a pharmaceutical company in Basel, Switzerland, has introduced its StrataXRT® innovative and film-forming wound dressing gel that easily spreads with only a small amount applied on the affected area of the skin. Companies in the radiation dermatitis market are taking cues from such companies to develop film-forming gels that provide symptomatic relief from acute inflammatory response, discomfort, and itching.
Film-forming gels are a game changer in the class of wound dressings that reduce redness and swelling post exposure toward radiotherapy. Such gels are being used to protect the compromised skin from microbial invasion and prevent bacterial growth. Thus, film-forming wound dressing gels are creating an optimum environment for reducing downtime and enable faster wound healing.
Scope of The Report
| Report Coverage | Details |
| Market Size By 2030 | USD 700 Million |
| CAGR from 2022 to 2030 | 5.1% |
| Largest Market | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2021 |
| Forecast Data | 2022 to 2030 |
| Key Players | 3M Company, Mölnlycke Health Care AB, Smith & Nephew plc, Integra Lifesciences Holdings Corporation, Intermed S.A., ConvaTec Group plc, and BMG PHARMA S.p.A. |
Traditional Chinese Medicine Holds Potential in Treatment of Carbuncles Post Radiotherapy
Traditional Chinese medicine (TCM), Jiawei Simiao Yongan Gao, holds promising potentials in minimizing the impact of radio-dermatitis in patients with neck and head cancer. Companies in the radiation dermatitis market are capitalizing on this opportunity to innovate in pastes that improve the symptoms of skin reaction caused due to radiotherapy. They are improving their production capabilities in clear and light drugs that can enter the lung meridian directly.
Honeysuckle is emerging as one of the key ingredients in TCM for the treatment of carbuncles. Manufacturers in the radiation dermatitis market are experimenting with medicines containing angelica sinensis, which appears to nourish and activate the blood and relieve pain by promoting coronary circulation.
Report Highlights
In terms of product, the global radiation dermatitis market has been classified into oral medication, topical, and dressings. The topical segment dominated the global radiation dermatitis market in 2020 and the trend is projected to continue during the forecast period. The growth of the segment can be attributed to the fact that topical agents are the most prescribed products in the radiation dermatitis treatment market, especially hydrophilic creams and corticosteroids. Hydrophilic creams are extensively used across the globe, as these provide hydration and soothing relief from itching, and other symptoms of radiation dermatitis.
Based on distribution channel, the global radiation dermatitis market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment dominated the global radiation dermatitis market and the trend is anticipated to continue during the forecast period. Radiation dermatitis can develop either during or even several months after radiation therapy. Hence, a retail pharmacy is likely to be driven by patients who are referred to purchase particular products by peer recommendation. Additionally, it is driven by proximity to local area and familiarity of use by loyal customers.
Asia Pacific dominated the global radiation dermatitis market in 2020 and the trend is anticipated to continue during the forecast period. The rise in population suffering from cancer in Asia Pacific has increased the number of patients opting for radiation therapy. Hence, the usage of radiation dermatitis treatment products is expected to increase during the forecast period. Asia Pacific is likely to be a highly lucrative market for radiation dermatitis treatment from 2021 to 2030. The market in the region is projected to expand at a high CAGR during the forecast period.
Key Players
Key players in the global radiation dermatitis market include 3M Company, Mölnlycke Health Care AB, Smith & Nephew plc, Integra Lifesciences Holdings Corporation, Intermed S.A., ConvaTec Group plc, and BMG PHARMA S.p.A.
Market Segmentation
By Product
-
- Oral Medication
- Corticosteroids
- Oral Analgesics & Antibiotics
- Topical
- Corticosteroids
- Hydrophilic Creams
- Topical Antibiotics
- Dressings
- Hydrogel
- Hydrocolloid
- No Sting Barrier film
- Honey Impregnated Gauze
- Silicone Coated Dressing
- Others
- Oral Medication
By Distribution Channel
-
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Radiation Dermatitis Market, by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38181
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333